Lidocaine Injection 2% ( DrugBank: Lidocaine )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
168	エーラス・ダンロス症候群	2

168. エーラス・ダンロス症候群

---

臨床試験数 : 13 /  薬物数 : 21 - (DrugBank : 11) / 標的遺伝子数 : 11 - 標的パスウェイ数 : 103

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05603741 (ClinicalTrials.gov)	November 10, 2022	24/10/2022	Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers	Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers	Ehlers-Danlos Syndrome;Anesthesia, Local	Drug: 0.9% Sodium Chloride Injection;Drug: Lidocaine Injection 2%	University of Calgary	Vanderbilt University Medical Center	Active, not recruiting	18 Years	N/A	All	155	Phase 4	Canada
2	NCT04036305 (ClinicalTrials.gov)	July 26, 2019	25/7/2019	Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers	Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers	Ehlers-Danlos Syndrome;Anesthesia, Local	Drug: 0.9% Sodium Chloride Injection;Drug: Lidocaine Injection 2%;Drug: Bupivacaine Injection 0.5%	Vanderbilt University Medical Center	University of Calgary	Enrolling by invitation	18 Years	N/A	All	230		United States